# Fermenta Biotech Ltd (FERMENTA)
> Exchange: NSE | Sector: Pharma | ISIN: INE225B01021

## Price
Current Price: ₹301.45
Day Change: -1.55%
52W High: ₹330
52W Low: ₹248.85
Market Cap: ₹847 Cr

## Valuation
P/E: 9.97
P/B: 2.18
EPS: ₹29.61
Book Value: ₹134.13
Dividend Yield: 0%

## Returns
1Y Return: -11.6%

## Profitability
ROE: 22.65%
ROCE: 0%
Debt/Equity: 0.29
Revenue Growth: -12.2%
Profit Growth: -65.9%
EBITDA Margin: 22.39%
Operating Margin: 14.26%

## About
Fermenta Biotech Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Fermenta Biotech Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:07.443Z
Price History Updated: 2026-05-25T05:33:20.600Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:33:20.600Z
Quant Updated: 2026-05-25T05:33:20.600Z
Sentiment Updated: 2026-05-25T05:33:20.600Z
Financials Status: current
Financials Updated: 2026-05-18T10:30:01.379Z
Financials Last Attempt: 2026-05-18T10:30:01.379Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2015)
Revenue: ₹139 Cr
Operating Profit: ₹26 Cr (OPM 19%)
Net Profit: ₹10 Cr
Tax: ₹14 Cr

## Annual P&L History
Mar 2015: Rev ₹139Cr | PAT ₹10Cr | OPM 19%
Mar 2016: Rev ₹142Cr | PAT ₹1Cr | OPM 11%
Mar 2017: Rev ₹155Cr | PAT ₹2Cr | OPM 13%

## Balance Sheet (Mar 2015)
Total Assets: ₹259 Cr
Total Liabilities: ₹259 Cr
Borrowings: ₹65 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Prashant Prabhakar Nagre, MD & Additional Director
- Krishna Vasantkumar Datla, Executive Vice-Chairman
- Sumesh  Gandhi CA, Group CFO & President
- Satish Azad Nadimpally Varma, Executive Director
- Anupama Datla Desai, Executive Director

---
Source: rupiya.io/stocks/fermenta
Disclaimer: For research and education only. Not investment advice.